Last reviewed · How we verify

Elonva — Competitive Intelligence Brief

Elonva (Elonva) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Other.

marketed Follicle-stimulating hormone receptor Other Small molecule Live · refreshed every 30 min

Target snapshot

Elonva (Elonva) — University Medical Centre Ljubljana.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Elonva TARGET Elonva University Medical Centre Ljubljana marketed Follicle-stimulating hormone receptor
Org 36286 CORIFOLLITROPIN ALFA Merck Sharp & Dohme Limited marketed Follicle-stimulating hormone receptor 2010-01-01
Urofollitropin FOLLITROPIN Serono marketed Gonadotropin [EPC] Follicle-stimulating hormone receptor 1986-01-01
Metformin and FSHr Metformin and FSHr Assistance Publique - Hôpitaux de Paris marketed Combination therapy: biguanide + gonadotropin receptor agonist Metformin: mitochondrial glycerophosphate dehydrogenase; FSHr: follicle-stimulating hormone receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Elonva — Competitive Intelligence Brief. https://druglandscape.com/ci/elonva. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: